Thyroid-Stimulating Hormone Receptor

Alternative Names

  • TSHR
  • Thyrotropin Receptor
  • LGR3
  • Thyroid Adenoma, Hyperfunctioning
  • Thyroid Carcinoma with Thyrotoxicosis
Back to search Result
OMIM Number

603372

NCBI Gene ID

7253

Uniprot ID

P16473

Length

190,686 bases

No. of Exons

11

No. of isoforms

3

Protein Name

Thyrotropin receptor

Molecular Mass

86830 Da

Amino Acid Count

764

Genomic Location

chr14:80,955,621-81,146,306

Gene Map Locus
14q31.1

Description

The thyroid hormones, produced by the thyroid gland, are essential for the proper development and differentiation of cells in the body and regulating the metabolism of fats, carbohydrates, and proteins in the body. Production of the thyroid hormone is stimulated by the Thyroid Stimulating Hormone (TSH), which is synthesized in the pituitary. The Thyroid Stimulating Hormone Receptor (TSHR) acts as a bridge between the TSH and the thyroid gland. These receptors, with binding sites for TSH molecules, are situated on the membranes of the follicular cells of the thyroid gland, and serve to act as mediators of the effect of TSH. Once activated by the binding of TSH, the receptor initiates a series of reactions that control the development and functioning of the thyroid gland. Apart from the thyroid, TSHR mRNA has also been detected in other tissues, such as lymphocytes, adipocytes, and neuronal cells. The TSHR protein contains multiple Leucine Rich Repeats (LRRs). Each LRR is coded for by a separate exon and consists of a beta sheet oriented towards the interior of the protein. It is believed that this structure plays a major role in binding the hormone.

Mutations in the TSHR gene have been identified in several people with subclinical hypothyroidism, hyperthyroidism, familial gestational hyperthyroidism, non-autoimmune hyperthyroidism, Grave's disease, and thyrotropin resistance.

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_000369.5:c.1295A>GUnited Arab EmiratesNC_000014.9:g.81143353A>GUncertain SignificanceNG_009206.1:g.192829A>G; NM_000369.5:c.1295A>G; NP_000360.2:p.Asn432Ser368268514
NM_000369.5:c.202C>TUnited Arab EmiratesNC_000014.9:g.81062179C>TBenign, Likely Pathogenic, Pathogenic, Uncertain SignificancePathogenicHypothyroidism, Congenital, Nongoitrous, 1NG_009206.1:g.111655C>T; NM_000369.5:c.202C>T; NP_000360.2:p.Pro68Ser142063461437071

Other Reports

Qatar

Isseh and Al-Sharkawy (1998) conducted a retrospective study to identify the causes of thyrotoxicosis in Qatar and detected 7 patients with toxic adenoma. [Isseh N, Al-Sharkawy W. Thyrotoxicosis in Qatar. Qatar Med J. 1998; 7(1):39-41.]

© CAGS 2024. All rights reserved.